Gemme Welcomes Advent Of French Biosimilar Substitution

But Protests Against Generic Price Cuts Amid ‘Unprecedented Inflationary Context’

French off-patent industry association Gemme has welcomed the entry into force of biosimilar substitution – but has protested against recent and ongoing price cuts for small-molecule generics in the context of unprecedented cost pressures.

Substitution icon switch
Biosimilar substitution now applies to filgrastim and pegfilgrastim in France • Source: Shutterstock

More from Biosimilars

More from Products